Key result
Clinical pharmacist-physician counselling significantly increased the percentage of patients achieving therapeutic INR levels from 37.2% before counselling to 74.4% after counselling (p < 0.001).
Why the study?
Does clinical pharmacist-physician counselling improve warfarin knowledge and therapeutic INR levels in patients taking warfarin?
Cross-Sectional (n=285)
Yes
Does clinical pharmacist-physician counselling improve warfarin knowledge and therapeutic INR levels in patients taking warfarin?
Absolute Event Rate: 74.4% vs 37.2%
p-value: p=<0.001
Clinical pharmacist and physician counselling significantly improves patients' knowledge about warfarin and increases the proportion of patients achieving therapeutic INR levels.
Counselling was associated with better INR control; leaves open whether RCTs would confirm benefit before practice change.
BACKGROUND: Health care professionals (HCP) are known key elements of effective patient's counselling and education. For patients taking warfarin, education about the dose, side effects, and toxicity is clearly identified as a cornerstone of achieving improved health and quality of life. The study objective was to evaluate the patients' knowledge about warfarin and assess the impact of the health care professionals' counselling in enhancing patients' knowledge in achieving warfarin therapeutic outcomes. METHOD: A six-month prospective multicentered study was conducted in three hospitals, enrolling 300 patients admitted to the cardiac care unit and internal medicine departments. Patients' warfarin knowledge and INR levels were assessed before and after the clinical pharmacist counselling. The main therapeutic outcome was the impact of the clinical pharmacist-physician counselling on improving patient's education and achieving therapeutic INR level. RESULTS: A higher mean knowledge about warfarin score was found after counselling as compared to before counselling (4.82 vs 13.2; p < 0.001). Likewise, the drug dose (1.05 vs 1.88), drug toxicity (0.41 vs 1.92), drug-drug and food-drug interactions (0.02 vs 1.89), therapeutic INR and general drug knowledge scores (2.66 vs 4.68) were significantly higher after as compared to before counselling (p < 0.001 for all variables). The percentages of patients who achieved therapeutic INR levels pre/post counselling was 37.2% and 74.4% respectively (p < 0.001). CONCLUSION: Based on the study findings, HCP play a major role in enhancing patients' knowledge about the factors that affect warfarin therapeutic outcomes. This study highlights the need to establish and develop strategies for appropriate warfarin utilization in Lebanon.
No takes yet. Share an insight, caveat, or question.
Choumane et al. (2018) conducted a cross-sectional in Patients taking warfarin for approved indications (n=285). Clinical pharmacist-physician counselling vs. Before counselling (baseline) was evaluated on Achievement of therapeutic INR levels (p=<0.001). Clinical pharmacist-physician counselling significantly increased the percentage of patients achieving therapeutic INR levels from 37.2% before counselling to 74.4% after counselling (p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: